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Review Article

Intestinal transplants: review of normal imaging
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Abstract
Intestinal transplant (IT) is one of the least common forms of organ transplant but is increasing both in volume of cases
and number of centers performing intestinal transplants, with the busiest centers in North America and Europe. IT can
be performed in isolation or as part of a multivisceral transplant (MVT). Intestinal failure either in the form of short
gut syndrome or functional bowel problems is the primary indication for IT. The normal post-surgical anatomy can be
variable due to both recipient anatomy in regard to amount of residual bowel and status of native vasculature as well
as whether the transplant is isolated or part of a multivisceral transplant. Complications of isolated IT and IT as part of
an MVT include complications shared with other types of organ transplants such as infection, rejection, post-transplant
lymphoproliferative disorder and graft versus host disease. Mechanical bowel complications of the graft include bowel
obstruction, stricture, leak, perforation and enterocutaneous fistula. Lastly, vascular complications of both the venous
and arterial anastomoses including stricture and pseudoaneurysm occur.

Indications
IT has become an established treatment option for patients
with intestinal failure. The number of cases and centers
performing IT in the United States has steadily increased
from 5 cases in 1990 to 146 cases in 2016.1 The number of
patients added to the IT waiting list also has increased, from
152 in 2012 to 195 new patients in 2016, with 270 patients
on the waiting list at the end of 2016.1,2 The most common
indication for isolated IT is intestinal failure, defined as an
inability of the GI tract to maintain adequate nutrition and/
or fluid balance. Intestinal failure may be secondary either
acquired or congenital causes. Intestinal failure is further
classified into short gut syndrome and functional bowel
problems.3 The most common underlying etiologies of
short gut syndrome in adults are intestinal ischemia, inflammatory bowel disease, trauma and infiltrating tumors such
as desmoids.4 Most other cases of IT are seen in patients
transitioning off total parenteral nutrition (TPN), which is
the standard of care for patients with pre-transplant intestinal failure. Currently, more than 40,000 patients in the
United States depend on TPN for survival.5 Unfortunately,
TPN is associated with a variety of common comorbidities,
including catheter-associated infections, metabolic bone
disease, TPN-induced cholestasis, loss of site for vascular

access and catheter occlusion.6 Patients who are TPN-dependent and subsequently require IT are also more likely to
require a MVT due to end-stage liver failure, which includes
the intestine and liver with or without the pancreas.7
Normal post-surgical bowel and
vascular anatomy
The isolated IT involves either transplantation of the entire
cadaveric small bowel, which is preferable, or a shorter
segment of small bowel from a living donor. The nature of
the surgery may vary dependent on what degree of stomach,
small bowel and large bowel the recipient retains. Typically,
there is a proximal end-to-side or side-to-side anastomosis
of the proximal donor intestine to the native recipient
duodenum/jejunum. For an MVT, there is often anastomosis between the donor stomach and the recipient proximal stomach. Distally, a second end-to-side anastomosis
is formed between the distal segment of the donor bowel
to recipient bowel, most commonly donor ileum to the
sigmoid colon with an end-to-side anastomosis (Figure 1).
A segment of ileum from the distal end-to-side anastomosis is extended to the abdominal wall with construction
of a temporary “chimney” ileostomy which allows for less
invasive access for endoscopic graft surveillance and biopsy.
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Figure 1. A 62-year-old female with history of short gut syndrome secondary to multiple bowel resections, nine days after IT. Schematic illustration (a) and UGI (b) of the abdomen demonstrate the proximal anastomosis (black arrow in a and b), most commonly
a side-to-side jejunojejunostomy. The distal end-to-side ileocolic anastomosis (dashed arrow in a, b) most commonly involves the
sigmoid colon. Chimney ileostomy (arrowhead in a) also noted.

The ileostomy is often taken down upon stabilization of immunosuppressive therapy. IT graft surveillance after that point is
typically done via colonoscopy.

tacrolimus neurotoxicity, CNS infections and metabolic disturbances post-transplant account for the vast majority of encephalopathic episodes.9

Post-operative nutritional support can be achieved via different
means. In our institution, if the patient has a gastrostomy tube,
that is converted to a gastrojejunostomy tube preoperatively.
Otherwise, a nasojejunal tube is placed for post-op feeding. We
avoid placement of intra-operative feeding jejunostomy tubes
due to increased risk of chronic enterocutaneous fistula.

Imaging evaluation
Pre-operatively, most if not all patients will undergo MDCT of
the chest, abdomen and pelvis with intravenous contrast and
neutral oral contrast agent; water, to assess native arterial and
venous vasculature, anatomy of the native abdominal viscera,
as well as to detect occult malignancy which may preclude the
patient from undergoing transplantation.10 We do not administer a positive oral contrast agent in the event that three dimensional reconstructions are needed. Fluoroscopic evaluation with
barium can assess for pre-operative enterocutaneous fistula as
well as to assess the length of the residual small bowel, however
this has been largely supplanted by MDCT.11 Although MDCT
has largely replaced fluoroscopy in both the pre-operative and
post-operative settings, fluoroscopic upper gastrointestinal series
with small bowel follow through is frequently obtained both as
an overview of native bowel anatomy as well as to assess bowel
motility/transit time.12

Preoperatively, multidetector CT (MDCT) with intravenous
contrast of the recipient may be performed to assess the caliber
and patency of the splanchnic vessels and guide the vascular
anastomoses. Both arterial and venous anastomoses need to be
performed (Figure 2). For isolated IT, if the recipient superior
mesenteric artery (SMA) is good quality and adequate length,
then a recipient SMA to donor SMA anastomosis is made by
extending either of the sides with the donor carotid or iliac artery.
If the recipient SMA is too short or poor quality, then a donor
SMA to recipient infra-renal abdominal aorta anastomosis is
made with an extension via an arterial graft. If the recipient superior mesenteric vein (SMV) is adequate length and caliber, then
an anastomosis between recipient SMV to donor SMV is made
with or without an extension graft, usually using donor iliac vein
or jugular vein. If the recipient SMV is inadequate due to short
length or narrow caliber, the venous anastomosis is made via
recipient inferior vena cava (IVC) to donor SMV with an extension graft from donor iliac vein or jugular vein. This situation
of mesenteric vein anastomosis directly to the IVC theoretically
increases the likelihood of development of hepatic encephalopathy via creation of a portosystemic shunt, however this is quite
uncommon, with only one case report documenting relapsing
encephalopathy due to a combination of post-transplant metabolic disturbances, dehydration and direct mesenteric to caval
shunt anatomy.8 Other causes of encephalopathy including

2 of 12

birpublications.org/bjr

Post-operatively, fluoroscopic studies allow for early evaluation
of graft anatomy, functional tone and motility as well as for the
detection of early and late postoperative complications including
bowel obstruction, perforation, entero-enteric or enterocutaneous fistulae as well as anastomotic leak or stricture. Optimally,
this is performed with water soluble oral contrast in the post-operative setting given potential for anastomotic leak. Color
doppler ultrasound is predominantly utilized in the postoperative setting as a tool to assess the donor and recipient vasculature, which can be performed on a portable basis and provides
accurate and early assessment for elevated mesenteric and intestinal wall arterial resistive indices as well as for arterial/venous
thrombosis, a potential early complication. MDCT, preferably
with the use of intravenous and oral positive contrast, is the
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Figure 2. Schematic illustration of an isolated IT demonstrates
normal vascular anastomoses, including the donor SMA to
the recipient infrarenal abdominal aorta (solid arrow) and
anastomosis of the donor SMV to the recipient IVC (dashed
arrow). SMA, superior mesenteric artery; SMV, superior mesenteric vein; IVC, inferior vena cava.
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acquisition of the upper abdomen to include the arterial anastomosis followed by a venous phase acquisition of the abdomen
and pelvis obtained 70 s after onset of contrast injection to
evaluate the venous anastomosis. For the CT angiogram and
the dual phase acquisition, no positive oral contrast is administered; to allow for three dimensional reconstructions as needed.
Tailored imaging including CT Enterography can be performed
as warranted in evaluation of IT.
Abdominal MRI may also be utilized in evaluation of the IT
patient; particularly in those who should not receive iodinated
IV contrast due to renal insufficiency or contrast allergy. It is of
greatest utility in evaluating vascular complications but MRI
Enterography can evaluate for signs of infection, mechanical
bowel complications such as obstruction and stricture. It may
be of lesser utility in the acutely ill IT patient given relatively
prolonged imaging times. We rarely utilize MRI for the evaluation of vascular anastomoses and reserve its use for patients
with contraindication to iodinated contrast material. Our
protocol uses a combination of both non-contrast time-offlight imaging as well as a gadolinium enhanced three dimensional gradient based MR angiography. We utilize a Group
II gadolinium agent, gadobutrol, regardless of renal function
based on risk assessment of gadolinium agents in the setting
of renal insufficiency as recently reviewed by the American
College of Radiology and European Society of Urogenital
Radiology guidelines.13,14
Normal Appearance of IT
The transplanted small bowel is commonly in a central location
within the abdomen. The normal transplanted bowel may appear
similar to normal native bowel. However, normal postoperative imaging findings after IT overlap with pathologic processes
given the inherent denervation of the transplant and diminished
lymphatic drainage. Short segments of mild luminal dilatation or
bowel wall/fold thickening are common, seen in approximately
one third of patients in the peri-transplant period (Figure 3).15
These findings typically persist in the first 3 months post-transplant.15 A small amount of mesenteric oedema/ascites is also
relatively common with mucosal hyperenhancement seen less
commonly in only 11% of patients.15

modality of choice for detection of complications including fluid
collections, abscesses, fistulae, as well as enteric and vascular
anastomotic complications. Routine CT evaluation is performed
with both intravenous and water soluble positive oral contrast.
We utilize a weight based dose of IV contrast varying between
100 and 150 ml of iodinated contrast. Intravenous contrast
is essential in detecting vascular compromise and enhancing
abnormalities such as abscess. Oral contrast is dilute iodinated
contrast and is valuable in assessing for enteric leak and enteric
fistula. In the early peri-operative period, oral contrast is crucial
given the potential for enteric anastomotic leak. Unless vascular
complications are suspected, images are acquired in a single
venous phase utilizing a 70 s time delay after onset of IV contrast
injection. If vascular complications are suspected, either a CT
angiogram or a dual phase protocol is performed depending on
the level of suspicion for an arterial or venous complication. The
dual phase acquisition is performed with both an arterial phase
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Complications of IT
Infection
The various forms of infection constitute the leading cause of
mortality after IT. Infection is the attributable cause of mortality
in up to 17.8% of all IT recipients, and in IT patients who had
expired, up to 76.2% of those had documented infections.16
Infection has also been attributed as the second most common
cause of allograft loss after rejection.17 The high level of immunosuppression as well as the high levels of intraluminal flora within
the transplanted bowel predispose the transplanted bowel to a
high infection risk, and almost all patients will experience an
infectious episode in the first month post-transplant. The large
volume of native lymphoid tissue within the transplanted bowel
also requires a higher degree of immunosuppression, which in
turn increase patient susceptibility to opportunistic infections
and malignancy.18

Br J Radiol;91:20180173
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Figure 3. A 55-year-old female 2 years after IT. Coronal (a) and axial (b) MDCT with oral contrast demonstrate a normal IT transplant with normal caliber small bowel with slight fold thickening in the jejunal loops (arrow in a). A right lower quadrant “chimney”
ostomy is present (arrow in b).

When there is a clinical concern for an infectious process,
MDCT with IV and positive oral contrast is our initial study of
choice. This is frequently performed to exclude a process that
can be intervened on such as an abscess which is readily identified on CT. Positive oral contrast is preferred to help identify
enteric leaks and fistula; if present as they may be the source
of an infectious process. If the patient had cannot tolerate IV
contrast, we will proceed with MDCT with positive oral contrast
but no IV contrast initially due to the ready availability of CT
but will subsequently perform contrast enhanced MRI Enterography to assess the bowel and solid abdominal organs if clinically
warranted.
Potential causes of infection include bacterial, viral, protozoan
and fungal organisms. IT infection is classified into two time
periods; immediate (<6 weeks) or later (>6 weeks) post-transplantation period.19 In the immediate post-transplantation
period, health care-associated infections, most commonly

Gram-negative bacteria such as Escherichia coli and fungal
Candida species, predominate. The most common sites include
the respiratory tract, peritoneal cavity and operative wound as
well as sites of catheterization. Intra-abdominal abscesses are
also common (Figure 4). Abscess in the setting of IT has the
typical imaging features of intra-abdominal abscess seen in other
clinical settings including low attenuation/fluid center, peripheral rim enhancement and variable presence of internal gas.
In the later post-transplantation period, similar causative organisms as in the immediate period are seen along with the addition
of a wide variety of viral etiologies including Cytomegalovirus
(CMV), Epstein-Barr Virus (EBV), Adenovirus and others. A
single center case series by Nagai et al demonstrated an incidence of CMV infection in 17% of adults and 12% of pediatric
patients following IT and MVT with a median onset of infection
347 days postoperative.20 Both EBV and Adenovirus are viral
species that remain latent in lymphoid tissue and patients are

Figure 4. A 56-year-old female 1 month after IT, presenting with fever, nausea, vomiting and abdominal pain. Coronal (a) and axial
(b) contrast-enhanced MDCT images demonstrate a well-defined peripherally enhancing fluid collection in the central abdomen
(arrow in a and b), confirmed as an abscess.
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Figure 5. A 44-year-old female 2 months after IT. Coronal (a) and axial MDCT (b, c) with oral contrast demonstrate abnormal soft
tissue in the mesentery (arrow in b) favored to represent a combination of conglomerate nodal tissue and ascites with small bowel
thickening (arrow in c). Small bowel biopsy confirmed acute enteritis and was positive for adenovirus. MDCT, multidetector CT.

at risk of reactivation after transplantation. Adenovirus is seen
most commonly in children and young adults, with a reported
incidence of 20% in a single series.21 The main clinical manifestation of Adenoviral enteritis is osmotic diarrhoea with or without
associated fever. Dissemination to secondary sites including
the lung, liver and pancreas is not uncommon.22 Adenovirus
involvement of other organs has a varied appearance. CT findings in the setting of an adenoviral pneumonia usually manifests as nonspecific extensive bilateral ground glass opacities
with or without consolidation.23 Hepatic involvement typically
manifests as a nonspecific hepatitis, with hepatomegaly and
periportal oedema, with ascites and gallbladder wall thickening
possible. Pancreatic involvement usually manifests with imaging
features of acute pancreatitis, which often times can be normal or

present with pancreatic enlargement, oedema and peripancreatic
inflammation.24
In the setting of an infectious enteritis, MDCT demonstrates
segmental or diffuse hypo- or hyperenhancing small bowel
mucosa most commonly with low density submucosal wall
thickening (Figure 5).25 Mesenteric lymphadenopathy can be
seen with both bacterial and viral organisms. MDCT appearance
of infectious enteritis and rejection may share similar imaging
findings, and endoscopic biopsy utilizing the chimney ileostomy
is often required for definitive diagnosis. Intra-abdominal ascites
is more commonly seen in the setting of rejection than infection
and can be a clue to the proper diagnosis, although this is not
a definitive finding (Figure 6).15 Other imaging modalities are

Figure 6. A 58-year-old male 1 week status post MVT. Coronal (a) and axial (b) MDCT demonstrates hyperenhancement of the
small bowel mucosa (arrows in a) and simple-fluid attenuation ascites (arrow in b). Intra-abdominal fluid washout grew Vancomycin resistant Enterococcus faecium species. MDCT, multidetector CT; MVT, multi visceral transplant.
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Figure 7. Two patients with acute rejection. A 28-year-old female 1 year status post MVT. Coronal MDCT (a) demonstrates mild,
diffuse small bowel wall thickening and increased mucosal enhancement (arrow) with ascites consistent with rejection. A 38-yearold male 1 year status post IT with acute rejection. Supine abdominal radiograph (b) and coronal MDCT (c) demonstrate wall
thickening/oedema of the walls of the small intestine (arrow in b) with loss of the normal fold pattern and mucosal hyperemia of
the small intestine (arrow in C) with ascites. MDCT, multidetector CT; MVT, multivisceral transplant.

of limited utility in the diagnostic evaluation of post-transplant
infection, although FDG PET-CT may be of benefit to assess for
occult infection.
Rejection
The incidence of acute cellular rejection occurred in 44.8% of
adult in IT recipients at 1 year and 53% at 2 years, making it the
most common complication following IT, and most often seen
in the first 6 months post-transplant.2,26,27 Chronic rejection is
far less common, occurring in approximately 10–15% of patients
receiving an isolated IT. The incidence, however, is rising as
graft survival increases. Diagnosis of acute rejection is based on
a combination of clinical signs and symptoms, endoscopy and
histologic findings. Routine post-transplant endoscopic surveillance via the “chimney” ileostomy is commonly performed and
varies by center. Once the ileostomy is closed, typically within

3–12 months, surveillance is performed most commonly via
colonoscopy. The sensitivity and specificity of routine endoscopic surveillance in detection of rejection was 50 and 90%,
respectively, while in symptomatic patients, the sensitivity and
specificity fell to 43 and 67%, respectively.28 The clinical findings
of acute and chronic rejection are similar and can include weight
loss, diarrhoea, fever and high-volume stooling.
On imaging, the MDCT appearance of acute rejection is nonspecific. Diffuse wall thickening with mucosal hyper- or hypoenhancement in the first 90 days with ascites is suggestive but not
diagnostic (Figure 7).29 A single-center study demonstrated
moderate ascites in 20 of 21 patients who had acute rejection
at the time of CT.15 There is a paucity of literature discussing
the MRI findings of rejection. In our experience, MR Enterography demonstrates similar nonspecific findings of bowel wall

Figure 8. A 45-year-old female 4 months status post IT. Axial T2 single shot fast spin echo (a) and axial contrast-enhanced fat
suppressed T1 (b) MR enterography images demonstrates areas of mild bowel wall thickening (arrow in a), mucosal enhancement
(arrow in b) and moderate small bowel dilatation. Small bowel biopsy several days prior to imaging demonstrated findings consistent with acute cellular rejection.
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Figure 9. A 54-year-old male 8 days after IT. Axial (a), sagittal (b) MDCT with oral contrast and water soluble contrast UGI (c)
demonstrate extraluminal oral contrast (arrow in a, b and c) just distal to the ligament of Treitz adjacent to the surgical anastomosis consistent with anastomotic leak. MDCT, multidetector CT.

thickening and mucosal hyperenhancement on contrast-enhanced imaging (Figure 8). Fluoroscopic findings include bowel
wall thickening, loss of mucosal fold pattern and hypomotility
of the intestinal allograft.29,30 In a single center study, loss of
mucosal fold pattern was identified in 4 of 17 allografts, all of
which demonstrated either acute or chronic rejection on histopathologic examination.30
Mechanical bowel complications
As with other types of bowel surgeries, postoperative mechanical
complications include obstruction, anastomotic stricture, anastomotic leak, perforation and fistula. MDCT is the most sensitive
and specific imaging test for the diagnosis of small bowel obstruction, while MRI may be utilized for the assessment of patients
with subacute obstructive symptoms.31 Abdominal radiographs,
Figure 10. A 51-year-old male 1 year status post IT. Water soluble contrast enema demonstrates abrupt narrowing of the
mid-to-distal sigmoid colon (arrow) consistent with an anastomotic stricture.

while commonly ordered in the emergent setting, are of limited
utility for diagnosis and surgical management of IT patients as
in most cases it is nearly impossible to identify the cause and site
of obstruction. If small bowel obstruction is suspected, we prefer
initial imaging with MDCT, optimally with IV and positive oral
contrast with the goal of determining the level and cause of the
obstruction. If CT is unrevealing and a low level obstruction is
suspected, we will move to either MR or CT with enterography
technique for further evaluation. MR is preferred if the patient
cannot tolerate IV iodinated contrast. We perform fluoroscopic
studies uncommonly for suspected obstruction but have found
contrast enemas occasionally useful for anastomotic strictures at
the enterocolic anastomosis.
Imaging findings of small bowel obstruction on MDCT with
IV contrast include dilated proximal bowel, greater than 3 cm
in caliber, with decompressed distal small bowel and colon.
Findings that are concerning for ischemia include bowel wall
oedema, interloop fluid or fat stranding, diminished bowel wall
enhancement and vascular engorgement.32
As many patients who have undergone IT have a poor nutritional
status, wound and anastomotic healing is commonly impaired
which can lead to anastomotic leak. If a proximal anastomotic
leak is suspected, our initial study of choice is a water soluble
contrast UGI with small bowel study. We reserve CT for negative fluoroscopic examinations with a high index of suspicion. If
a distal anastomotic leak is suspected, we will attempt a fluoroscopic small bowel study if the length of bowel proximal to the
anastomosis is relatively short as oral contrast dilution tends not
to be an issue in that setting. If the fluoroscopic study is negative or the allograft length is relatively long, we will perform
MDCT with intravenous and positive oral contrast to evaluate
for distal anastomotic leak. Postoperative GI fluoroscopic evaluation with water-soluble contrast can demonstrate leaks with
contrast extravasation near or adjacent to the proximal anastomosis (Figure 9). The more distal anastomosis is often more difficult to assess with fluoroscopy given the inherent low viscosity
of the water-soluble contrast and subsequent dilution. In our
experience, MDCT with oral contrast may be complementary to
the fluoroscopic examination and demonstrate a leak where the
fluoroscopic study failed to demonstrate a leak.
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Figure 11. A 55-year-old female 1 year status post IT. CT scan
with oral contrast demonstrates oral contrast on the skin surface (arrow) on the lower margin of the surgical site which
was suspicious for non-visualized enterocutaneous fistula.
This was subsequently confirmed on physical examination.

Anastomotic stricture is an uncommon complication but can
occur at either the proximal or distal anastomosis. Stricture will
present as smooth luminal narrowing on GI fluoroscopic evaluation with pre-stenotic dilatation (Figure 10).
While uncommonly encountered, enterocutaneous fistulae can
be associated with a mortality rate as high as 6–33%, with electrolyte abnormalities, sepsis and malnutrition being the most
common causes of death.33 In the setting of suspected enterocutaneous fistula, we prefer to initially perform a fluoroscopic
fistulogram if there is a suspected fistula on the skin surface. This
involves cannulation of the cutaneous fistula opening, gentle
injection of water soluble contrast agent and fluoroscopic images
to visualize the tract and potential connection to adjacent bowel
loops.34 If there is no identified fistula on the abdominal wall, a
fluoroscopic UGI with small bowel study is our second choice;
preferably with thin barium as the contrast agent. If this examination is unrevealing we will proceed with MDCT with oral
and intravenous contrast with the goal of either identifying the
fistula tract or extravasated oral contrast on the skin surface.
GI fluoroscopic studies can be normal if the fistula is small in
size or obscured due to overlapping contrast opacified bowel
loops. When evaluating for possible enterocutaneous fistula

Figure 12. A 52-year-old female 17 years after MVT. Coronal maximum intensity PET image (a) and axial fused PET-CT images of
the neck (b), chest (c) and abdomen (d) demonstrates an enlarged hypermetabolic right supraclavicular lymph node (arrow in
b), a focus of hypermetabolism in the interatrial septum (arrow in c) and hypermetabolic nodal tissue along the anterior gastric
wall (arrow in d). Tissue sampling of the supraclavicular node revealed monomorphic PTLD. MVT, multivisceral transplant; PET,
positron emission tomography; PTLD, post transplant lymphoproliferative disorder
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Figure 13. A 37-year-old male 2 months after IT. Curved coronal reformatted image from MDCT (a) and venogram (b) prior
to balloon dilatation demonstrates stricture at the anastomosis of the donor SMV to recipient IVC (arrow). MDCT, multidetector CT; SMV, superior mesenteric vein; IVC, inferior vena cava.

with MDCT, oral contrast is optimal and may demonstrate oral
contrast within loops of small bowel extending to the adjacent
skin surface (Figure 11), although a direct communication may
be difficult to directly visualize. Associated complications such
as abscess or ileus can also be ascertained based on the MDCT
findings.

Figure 14. A 61-year-old female 1 month after IT who presented
emergently with severe bleeding from a previously placed
abdominal drain. Superior mesenteric angiogram demonstrates a catheter within the SMA conduit with active extravasation near the anastomosis of the SMA conduit and native
abdominal aorta (arrow). SMA, superior mesenteric artery.

Posttransplant Lymphoproliferative Disorder
The prevalence of posttransplant lymphoproliferative disorder
(PTLD) remains high, with an incidence of 7–11% in isolated
IT patients and ranging from 13–33% in MVT patients.35 The
highest incidence is in the first year after transplantation when
the level of immunosuppression is highest. The spectrum of
disease ranges from lymphoid hyperplasia to frank neoplasm
such as high-grade B cell lymphoma. The vast majority of
cases result from proliferation of EBV and resultant B-lymphocyte proliferation. CMV has also been implicated in the EBVseronegative population.36 The anatomic distribution of PTLD
is influenced by the allograft itself, and PTLD can be subdivided
into nodal and extranodal varieties depending upon the primary
site of disease burden.37,38 Clinically, most patients are asymptomatic in the early stages of the disease, however, subsequently
develop a constellation of nonspecific symptoms including
unexplained fever, lymphadenopathy, night sweats, fatigue and
allograft dysfunction which, in the setting of IT, can present as
nausea, vomiting and diarrhoea.
In cases of suspected PTLD, MDCT with IV contrast is our
initial preferred modality to identify apparent masses given
ready availability and cost effectiveness. If PTLD of the GI tract
is specifically of concern, we perform CT or MR with Enterography technique with MR Enterography preferably utilized in
patients with contraindications to IV contrast. MR Enterography is preferred in the paediatric population given the lack
of ionizing radiation. FDG-18 PET-CT may be utilized to look
for occult disease, clarify ambiguous findings as well as follow
up of treatment response. Small bowel involvement most
commonly occurs in the distal jejunum and ileum, however
can be seen throughout the allograft. Findings of PTLD on
MDCT in the setting of IT includes diffuse wall thickening
and dilatation, eccentric polypoid mass, luminal ulcerations
and short-segment intussusceptions.39 Whole-body positron
emission tomography/CT can be useful in assessing for occult
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Figure 15. A 35-year-old female with a history of pancreatic neuroendocrine carcinoma with liver metastases and extensive
mesenteric vascular involvement who is 10 months status post IT with MVT. Anterior planar Indium-111 octreotide scan images
of the chest (a) and abdomen (b) demonstrate radiotracer accumulation in recurrent malignancy in subcarinal and right hilar
lymph nodes (black arrows). No metastases is present involving the allografts. Axial contrast enhanced CT scan of the chest (c)
demonstrates subcarinal and right hilar adenopathy corresponding to the areas of increased uptake on octreotide scan (white
arrows). MVT, multivisceral transplant.

disease, in resolving equivocal clinical or imaging findings as
well as to gauge treatment response (Figure 12).38 Imaging
findings are similar to those seen in Hodgkin and non-Hodgkin Lymphomas. Both nodal and extranodal sites of disease
demonstrate intense 18F-FDG uptake, with the more aggressive subtypes of PTLD demonstrating significantly higher
standardized uptake values (SUV) compared with the less
aggressive subtypes. MRI can demonstrate T1 hypointense
and mildly T2 hyperintense solid organ lesions with variable enhancement.40 PTLD of the GI tract may demonstrate
circumferential wall thickening, nodular masses, aneurysmal
dilatation of bowel and areas of ulceration. On MR, PTLD of
the GI tract may have low signal intensity on both T1 and T2
imaging and is relatively hypovascular on contrast enhanced
MRI.38
Graft vs Host Disease
Graft versus host disease (GVHD) occurs in 7–9% of IT recipients, likely due to the large volume of lymphoid cells accompanying the graft.41 Multivisceral graft recipients tend to be more
likely than isolated IT recipients to develop GVHD.42 GVHD
can present in an early/acute (<100 days) or late/chronic (>100
days) form.43 Clinically, the skin is the most common organ
system affected, with a typical maculopapular rash, pruritus
and pain. Patients can develop bone marrow suppression. The
transplanted organs themselves are not involved but native organ
involvement can occur.44 Definitive diagnosis can be made with
histopathologic correlation. Because the skin is most common
organ involved, cutaneous biopsy of an affected skin site can aid
in the histologic diagnosis of GVHD. If solid organ involvement
is suspected, MDCT with IV contrast is performed to aid in
targeting site of biopsy.41
Vascular complications
Vascular complications include thrombosis, anastomotic hemorrhage, pseudoaneurysm and stricture. Thrombosis can be
either arterial or venous and can result in graft ischemia/infarction requiring at least a partial enterectomy. Pseudoaneurysm
formation most commonly occurs near the anastomosis and
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commonly requires surgical revision or a stent graft.28 The development of a pseudoaneurysm can be best prevented by secure
closure of the anastomosis between the donor SMA and recipient
aorta.28 Vascular strictures are uncommon; venous strictures
occur more frequently than arterial strictures (Figure 13).45 For
the evaluation of suspected arterial and venous complications
of the intestinal allograft, we utilize contrast enhanced CTA or
CTV for initial evaluation due to its relative availability, short
imaging times and high spatial resolution. MRA and MRV are
utilized in the setting of contraindication to iodinated contrast
but in the acutely ill patient may be more challenging to acquire
high quality images. We personally have found limited utility for
ultrasound evaluation of the arterial supply and venous drainage
of the intestinal graft but in the setting of MVT, ultrasound is
useful in the evaluation of the transplanted liver and/or pancreas
vasculature. Catheter angiography should be reserved for emergent indications, equivocal imaging findings or for treatment
purposes (Figure 14).
Recurrence of tumor
In the pre-transplant patient, tumors such as desmoid and
neuroendocrine tumors which may primarily involve the root
of the mesentery have a tendency to invade adjacent vasculature, making surgical resection nearly impossible. The most
recent IT data show that 17% of adults have neoplastic disease
as their indication for transplant.46 In a series of 21 patients
at the University of Miami, 6 patients who obtained an IT
with neoplastic disease as their indication had recurrence of
the neoplasm (Figure 15).47 In the cases of desmoid tumor
recurrence, all occurred in the recipient native tissues and not
the allograft itself and were subsequently resected if possible
without negative effect on the allograft. For neuroendocrine
tumors, there is limited data available. A single center study
of 13 patients who underwent MVT for treatment of primary
abdominal neuroendocrine tumor demonstrated recurrence in
5 of 12 patients who survived surgery. One patient had recurrent disease in the liver and another in mediastinal lymph
nodes; both of these patients succumbed to their disease. The
remaining three patients had asymptomatic recurrence with
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the sight of recurrence not specified and were described as
healthy and functional.48
When recurrence of tumor is suspected, MDCT with IV
contrast of the thorax, abdomen and pelvis is our initial
screening study of choice. Non contrast CT of the thorax
and MR of abdomen and pelvis is preferred for patients with
contraindications to iodinated contrast. The utility of further
imaging is driven both by findings on the CT as well as the type
of original malignancy. We have found Indium-111 octreotide
scan and, more recently, gallium-68 dotatate PET-CT useful in
the evaluation of neuroendocrine tumor recurrence and monitoring of therapeutic response.

Conclusion
IT in isolation or as part of a MVT is the definitive treatment of
intestinal failure. Radiologists who encounter the IT transplant
patient must be familiar with the typical post-operative anatomy
and imaging appearance of IT. Equally important is an understanding of the wide range of potential complications after IT,
including infection, rejection, mechanical bowel complications,
vascular compromise and neoplastic conditions such as PTLD.
The Radiologist plays an essential role in screening this patient
population for complications and directing the appropriate
workup. Imaging and accurate interpretation of the imaging
are both critical in the detection and diagnosis of many of the
complications seen after IT.
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